Concepedia

David D. Christ

DD

41

Publications

2.3K

Citations

28

H-Index

1985

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

DuPont (United States)

Wilmington University

Experimental Station

Bristol-Myers Squibb (Germany)

David D. Christ is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1985–2017

41

Publications

41

Metabolic basis for a drug hypersensitivity: antibodies in sera from patients with halothane hepatitis recognize liver neoantigens that contain the trifluoroacetyl group derived from halothane.

J G Kenna, Hiroaki Satoh, David D. Christ et al. · Journal of Pharmacology and Experimental Therapeutics · 1988 · 211 citations

Identification and Characterization of Efavirenz Metabolites by Liquid Chromatography/Mass Spectrometry and High Field NMR: Species Differences in the Metabolism of Efavirenz

Abdul Mutlib, Hua Chen, Gregory A. Nemeth et al. · Drug Metabolism and Disposition · 1999 · 141 citations

Human anti-endoplasmic reticulum antibodies in sera of patients with halothane-induced hepatitis are directed against a trifluoroacetylated carboxylesterase.

Hiroaki Satoh, Brian M. Martin, A H Schulick et al. · Proceedings of the National Academy of Sciences · 1989 · 137 citations · Full text

, , +19

Discovery of γ-Lactam Hydroxamic Acids as Selective Inhibitors of Tumor Necrosis Factor α Converting Enzyme:  Design, Synthesis, and Structure−Activity Relationships

James J.‐W. Duan, Lihua Chen, Zelda R. Wasserman et al. · Journal of Medicinal Chemistry · 2002 · 119 citations · Full text

Enflurane Metabolism Produces Covalently Bound Liver Adducts Recognized by Antibodies from Patients with Halothane Hepatitis

David D. Christ, J G Kenna, William Hammerer et al. · Anesthesiology · 1988 · 115 citations · Full text

, , +21

Rows per page

1–5 of 41